Gene therapy cocktail takes aim at Hard-to-Treat melanoma
NCT ID NCT01397708
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase trial tested a new approach for people with advanced melanoma that cannot be removed by surgery. The treatment combines a gene therapy injected directly into tumors with an oral drug that activates the therapy. The goal was to see if the combination is safe and tolerable. 26 participants were enrolled, and the study is now complete.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
a gene therapy (Ad-RTS-hIL-12) injected into tumors plus an oral activator drug (veledimex)
What this could lead to
If it works, this could point toward a new way to treat advanced melanoma by boosting the immune system directly inside tumors.
What could go wrong
This is an early-phase trial with only 26 people, so results may not apply broadly. The treatment involves gene therapy and can cause side effects like inflammation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atlantic Melanoma Center
Morristown, New Jersey, 07960, United States
-
Fletcher Allen Health
Burlington, Vermont, 05401, United States
-
Indiana University Health Goshen Center for Cancer Care
Goshen, Indiana, 46526, United States
-
James Graham Brown Cancer Center
Louisville, Kentucky, 40202, United States
-
Mary Crowley Cancer Research Center
Dallas, Texas, 75201, United States
-
Oncology Specialists
Park Ridge, Illinois, 60068, United States
-
St. Lukes
Easton, Pennsylvania, 15232, United States
-
The Angeles Clinic
Los Angeles, California, 90404, United States
-
Washington University
St Louis, Missouri, 63110, United States